ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 092,80
-0,15%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Adial Pharmaceuticals Inc (ADILW)

  7. Adial Pharmaceuticals Inc (ADILW) Actualités

ADILW

Adial Pharmaceuticals (ADILW)

Adial Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ADILW
DateHeureSourceTitreSymboleSociété
05/06/202414h30GlobeNewswire Inc.Adial Pharmaceuticals Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
29/05/202414h30GlobeNewswire Inc.Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6thNASDAQ:ADILWAdial Pharmaceuticals Inc
15/05/202414h30GlobeNewswire Inc.Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
22/04/202414h30GlobeNewswire Inc.Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
10/04/202414h30GlobeNewswire Inc.Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
02/04/202414h30GlobeNewswire Inc.Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
02/03/202401h00GlobeNewswire Inc.Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross ProceedsNASDAQ:ADILWAdial Pharmaceuticals Inc
28/02/202415h30GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
13/02/202415h15GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
18/01/202414h30GlobeNewswire Inc.Adial Announces Appointment of Tony Goodman as Chief Operating OfficerNASDAQ:ADILWAdial Pharmaceuticals Inc
20/12/202315h00GlobeNewswire Inc.Adial Pharmaceuticals Receives Final Reimbursement Payment from AdovateNASDAQ:ADILWAdial Pharmaceuticals Inc
29/11/202322h05GlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementNASDAQ:ADILWAdial Pharmaceuticals Inc
14/11/202323h02GlobeNewswire Inc.Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
31/10/202313h30GlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine ConferenceNASDAQ:ADILWAdial Pharmaceuticals Inc
25/10/202314h00GlobeNewswire Inc.Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader WebinarNASDAQ:ADILWAdial Pharmaceuticals Inc
24/10/202322h30GlobeNewswire Inc.Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:ADILWAdial Pharmaceuticals Inc
20/10/202314h00GlobeNewswire Inc.Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:ADILWAdial Pharmaceuticals Inc
19/10/202316h30GlobeNewswire Inc.Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company’s Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug DependenceNASDAQ:ADILWAdial Pharmaceuticals Inc
18/10/202314h00GlobeNewswire Inc.Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership AwardNASDAQ:ADILWAdial Pharmaceuticals Inc
28/09/202313h00GlobeNewswire Inc.Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
05/09/202314h30GlobeNewswire Inc.Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ADILWAdial Pharmaceuticals Inc
28/08/202314h30GlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on AlcoholismNASDAQ:ADILWAdial Pharmaceuticals Inc
23/08/202314h30GlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementsNASDAQ:ADILWAdial Pharmaceuticals Inc
21/08/202314h30GlobeNewswire Inc.Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
04/08/202314h30GlobeNewswire Inc.Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement and Reduce the Public FloatNASDAQ:ADILWAdial Pharmaceuticals Inc
11/07/202314h30GlobeNewswire Inc.Adial Provides Business Update Following Favorable Comments from US and EU Regulatory MeetingsNASDAQ:ADILWAdial Pharmaceuticals Inc
01/06/202315h00GlobeNewswire Inc.Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9thNASDAQ:ADILWAdial Pharmaceuticals Inc
12/05/202314h30GlobeNewswire Inc.Adial Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
10/05/202314h30GlobeNewswire Inc.Adial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate’s Assets and BusinessNASDAQ:ADILWAdial Pharmaceuticals Inc
30/03/202322h05GlobeNewswire Inc.Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADILW

Dernières Valeurs Consultées

NYSE
MCD
McDonalds
EU
HO
Thales
FTSE
UKX
FTSE 100
NASDAQ
AMZN
Amazon.com
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
NYSE
KO
Coca Cola
EU
SGO
Cie de SaintGobain
EU
RI
Pernod Ricard
EU
ML
Michelin
NYSE
JPM
JP Morgan Chase
EU
GLE
Societe Generale
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés